Insider Transactions in Q2 2022 at Mannkind Corp (MNKD)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 18
2022
|
David Thomson EVP Genl Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,001
-0.8%
|
$18,003
$3.19 P/Share
|
May 18
2022
|
Steven B. Binder |
SELL
Payment of exercise price or tax liability
|
Direct |
5,972
-0.81%
|
$17,916
$3.19 P/Share
|
May 18
2022
|
Stuart A Tross Chief People & Workpl Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,941
-0.71%
|
$17,823
$3.19 P/Share
|
May 18
2022
|
Alejandro Galindo EVP Endocrine Business Unit |
SELL
Payment of exercise price or tax liability
|
Direct |
4,789
-0.62%
|
$14,367
$3.19 P/Share
|
May 18
2022
|
Joseph Kocinsky Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,383
-0.71%
|
$16,149
$3.19 P/Share
|
May 18
2022
|
Michael Castagna Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,434
-0.78%
|
$49,302
$3.19 P/Share
|
May 10
2022
|
Steven B. Binder |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+12.82%
|
-
|
May 10
2022
|
Joseph Kocinsky Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+12.35%
|
-
|
May 10
2022
|
Stuart A Tross Chief People & Workpl Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+11.38%
|
-
|
May 10
2022
|
David Thomson EVP Genl Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+12.51%
|
-
|
May 10
2022
|
Alejandro Galindo EVP Endocrine Business Unit |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+12.15%
|
-
|
May 10
2022
|
Michael Castagna Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
565,000
+12.68%
|
-
|